Kodiak Sciences (KOD) Accumulated Depreciation (2017 - 2025)
Kodiak Sciences' (KOD) quarterly Accumulated Depreciation came in at $59.5 million in Q4 2025, up 44.13% YoY from $41.3 million in Q4 2024, and up 44.13% on a QoQ basis from $41.3 million in Q4 2024.
Analysis
Kodiak Sciences (KOD) Accumulated Depreciation (2017 - 2025) Analysis & Trends
Kodiak Sciences (KOD) has 9 years of Accumulated Depreciation data on file, last reported at $59.5 million in Q4 2025.
- Quarterly Accumulated Depreciation rose 44.13% year-over-year to $59.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $59.5 million (up 44.13% YoY) and the FY2025 annual result came in at $59.5 million, up 44.13% from the prior year.
- Accumulated Depreciation climbed to $59.5 million in Q4 2025, from $41.3 million in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $59.5 million in Q4 2025 to a low of $2.9 million in Q4 2021.
- A 5-year average of $26.6 million and a median of $22.6 million in 2023 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2021 — Accumulated Depreciation surged 35.44% — and 2023, when it surged 235.4%.
- Tracing KOD's Accumulated Depreciation over 5 years: stood at $2.9 million in 2021, then surged by 128.79% to $6.7 million in 2022, then surged by 235.4% to $22.6 million in 2023, then jumped by 82.96% to $41.3 million in 2024, then jumped by 44.13% to $59.5 million in 2025.
- The last three Accumulated Depreciation figures came in at $59.5 million (Q4 2025), $41.3 million (Q4 2024), and $22.6 million (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Kodiak Sciences | 2.21 Bn | 2.21 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 59.47 Mn |
| Dec 31, 2024 | 41.26 Mn |
| Dec 31, 2023 | 22.55 Mn |
| Dec 31, 2022 | 6.72 Mn |
| Dec 31, 2021 | 2.94 Mn |
| Dec 31, 2020 | 2.17 Mn |
| Dec 31, 2019 | 1.77 Mn |
| Dec 31, 2018 | 1.69 Mn |
| Sep 30, 2018 | 1.82 Mn |
| Dec 31, 2017 | 1.45 Mn |